Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody

被引：0
|
作者：
Buhmann, R. [1 ]
Stanglmaier, M. [2 ]
Simoes, B. [3 ]
Menzel, H. [4 ]
Peschel, C. [4 ]
Ruf, P. [2 ]
Lindhofer, H. [2 ]
Kolb, H. -J. [3 ]
机构：
[1] LMU, Klinikum Grosshadern, Munich, Germany
[2] TRION Res, Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] TU, Klinikum Rechts Isar, Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [31] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
    Reactions Weekly, 2001, 855 (1) : 7 - 7
  • [32] PHARMACOKINETICS AND EXPOSURE-RESPONSE FOR REGN1979, A BISPECIFIC ANTI-CD20 X ANTI-CD3 ANTIBODY, IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA.
    Yang, F.
    Zhu, M.
    Toroghi, M.
    Putluri, D.
    Yan, H.
    Davis, J.
    DiCioccio, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S120 - S120
  • [33] Combination treatment of bullous skin GVHD with anti-CD20 and anti-CD25 antibodies.
    Szabolcs, P
    Reese, M
    Yancey, K
    Hall, RP
    Joanne, K
    BLOOD, 2000, 96 (11) : 350B - 350B
  • [34] Donor CD8+ T cells mediate GVL without GVHD in recipients conditioned with Anti-CD3 mAb.
    Zhang, Chunyan
    Lou, Jingwei
    Li, Naninong
    Todorov, Ivan
    Lin, Chia-Lei
    Cao, Yu-An
    Contag, Christopher H.
    Kandeel, Fouad
    Forman, Stephen
    Zeng, Defu
    BLOOD, 2006, 108 (11) : 61A - 61A
  • [35] A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
    Ran Zhang
    Chenjun Tang
    Huaizu Guo
    Bo Tang
    Sheng Hou
    Lei Zhao
    Jianwu Wang
    Fangrong Ding
    Jianmin Zhao
    Haiping Wang
    Zhongzhou Chen
    Yunping Dai
    Ning Li
    Scientific Reports, 8
  • [36] Novel anti-CD20 monoclonal antibody shows promise as therapy for RA
    Nature Clinical Practice Rheumatology, 2008, 4 (12): : 623 - 623
  • [37] Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Patel, Krish
    Michot, Jean-Marie
    Chanan-Khan, Asher
    Ghesquieres, Herve
    Bouabdallah, Kamal
    Byrd, John C.
    Cartron, Guillaume
    Portell, Craig A.
    Solh, Melhem
    Tilly, Herve
    Wierda, William G.
    McGovern, Patricia
    Johnson, Chelsea
    Garcha, Raman
    Ribrag, Vincent
    Brisou, Gabriel
    Liebowitz, David
    Phillips, Tycel
    BLOOD, 2021, 138
  • [38] A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
    Zhang, Ran
    Tang, Chenjun
    Guo, Huaizu
    Tang, Bo
    Hou, Sheng
    Zhao, Lei
    Wang, Jianwu
    Ding, Fangrong
    Zhao, Jianmin
    Wang, Haiping
    Chen, Zhongzhou
    Dai, Yunping
    Li, Ning
    SCIENTIFIC REPORTS, 2018, 8
  • [39] A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia
    Liu, Jia
    Yao, Han
    Tao, Jun
    Feng, Yimei
    Zhang, Xi
    BLOOD, 2024, 144
  • [40] Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.
    Kiewe, P
    Hasmüller, S
    Kahlert, S
    Heinrigs, M
    Rack, B
    Marmé, A
    Korfel, A
    Thiel, E
    Sommer, H
    Untch, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 173S - 173S
12345